Miwa Takai
Inventor
Stats
- 15 US patents issued
- 17 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 15 US Patents Issued
- 17 US Applications Filed
- 52 Total Citation Count
- Oct 22, 2013 Most Recent Filing
- Dec 17, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
Santen Pharmaceutical Co., | 1
| 2006
|
SANTEN PHARMACEUTICAL CO., LTD. | 1
1 6 2 2 4 2 3 | 2001
2005 2007 2008 2009 2011 2012 2013 |
AYUMI PHARMACEUTICAL CORPORATION | 2
2 2 4 | 2006
2007 2009 2011 |
Inventor Addresses
Address | Duration |
---|---|
Ikoma, JP | Aug 30, 11 - Mar 10, 15 |
Ikoma-shi, JP | Apr 30, 09 - Feb 13, 14 |
Nara, JP | May 19, 11 - May 19, 11 |
Osaka, JP | Jun 10, 03 - Sep 29, 05 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 3 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 16 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 11 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
8975256 | 2015 | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity | 0 |
8664221 | 2014 | Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent | 1 |
2014/0045,842 | 2014 | METHOD FOR TREATING AN INFLAMMATORY DISEASE BY ADMINISTERING A 1,2,3,4-TETRAHYDROQUINOXALINE COMPOUND CONTAINING A PHENYL GROUP HAVING A SULFONIC ACID ESTER STRUCTURE INTRODUCED THEREIN AS A SUBSTITUENT | 2 |
2013/0303,537 | 2013 | 1,2,3,4-TETRAHYDROQUINOXALINE COMPOUNDS HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY | 4 |
8580784 | 2013 | Method for treating a disease related to the glucocorticoid receptor | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.